Parliamentary Search

Early day motion tabled by primary sponsor Patsy Calton (Liberal Democrat), on Tuesday, 26 October 2004, in the House of Commons. It is signed by 42 members in total.

CONTAMINATED BLOOD PRODUCTS PUBLIC INQUIRY

That this House notes the severe illness and deaths of haemophiliacs and some partners from HIV and hepatitis C, caused by the use of contaminated blood products, and the potential for future deaths from vCJD; and supports the Haemophilia Society in its call for an independent public inquiry into the contamination of haemophilia treatment since the 1970s, in particular the failure to make the UK self-sufficient in blood products, the failure in some parts of the UK to make a timely switch to virally inactivated treatment when this became available from 1985 and the failure to make timely provision of genetically-engineered recombinant Factor VIII and IX for all haemophiliacs.

Amendments

The Early day motion has received an amendment.

CONTAMINATED BLOOD PRODUCTS PUBLIC INQUIRY (1816A1)
The Early day motion has received an amendment sponsored by Michael Connarty (primary, Labour) and tabled on Thursday, 4 November 2004. It has been signed by 12 members in total.
Line 4, leave out from 'inquiry' to end and insert 'into the use of contaminated blood products in the treatment of haemophilia and in transfusions in the past; while recognising the progress made in the term of the present Labour government in allocating funds to provide non blood based recombinant clotting products for throughout the UK and a fund of approximately ??100 million to provide payments to all who are living with Hepatitis C, and urge the government to extend the payments to the families of those who have died as a result of contaminated blood products.'

Secondary information

Type
Early day motion
Reference
1816 
1816A1 
Session
2003-04
Subjects
Contamination Blood Haemophilia
Link
View this Early day motion on www.parliament.uk